anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Aravive · pitchdeck

Aravive | Investor Presentation Deck | 39 slides

39 pages · 3 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Aravive | Investor Presentation Deck | 39 slides

Aravive · 2022-09
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON
Narrative range 8 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 3 slides 100% 3/3 slides 100% 3/3 slides · 14 hits
— 0/3 slides
— 0/3 slides
33.3% 1/3 slides 100% 3/3 slides 100% 3/3 slides Agitate (Make it worse) 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides
— 0/2 slides
Solution (Provide relief) 3 slides 100% 3/3 slides 100% 3/3 slides · 12 hits
— 0/3 slides
66.7% 2/3 slides 33.3% 1/3 slides 100% 3/3 slides
— 0/3 slides

Slide inventory

39
every slide · same image gating as the playbook
01
Slide 1
Includes company logo, ticker symbol, and a representative photo of a patient.front_matter
Open slide detail
02
other
Open slide detail
03
present_solution
Open slide detail
04
The slide uses academic citations to establish the clinical relevance of the target protein.frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
05
Includes a scientific diagram of the signaling pathway and references to academic literature.frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
06
Includes a bifurcation diagram illustrating the relationship between SNAIL and ZEB mRNA levels in different cell phenotypes.frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
07
The slide uses a visual comparison of biological mechanisms to argue for the superiority of the company's 'Decoy AXL Receptor' approach.compare_peers
Open slide detailBeat · Agitate (Make it worse)
08
The slide uses a two-column layout to contrast the drug's engineering/profile with its biomarker/IP strategy.present_solution
Open slide detailBeat · Agitate (Make it worse)
09
The slide uses a standard organizational structure layout with headshots and a logo grid for credibility.other
Open slide detailBeat · Solution (Provide relief)
10
The slide uses a horizontal bar chart format to represent clinical trial stages for different drug combinations.plan_implementation
Open slide detailBeat · Solution (Provide relief)
11
The pie chart visualizes the relative size of the patient populations described in the list.size_opportunity
Open slide detailBeat · Solution (Provide relief)
12
front_matter
Open slide detailLoop · Quick Win Big Bet
13
The slide uses a process flow diagram to show the Phase 1b study arms.show_traction
Open slide detailLoop · Quick Win Big Bet
14
Includes specific clinical metrics (ORR, mPFS, mOS) comparing patients above and below the Minimal Efficacious Concentration (MEC).analyze_data
Open slide detailLoop · Quick Win Big Bet
15
The slide includes two scatter plots with error bars and two summary tables of experimental data.analyze_data
Open slide detailLoop · Quick Win Big Bet
16
The slide uses a swimmer plot (left) and a waterfall plot (right) to visualize clinical response.show_traction
Open slide detail
17
The slide highlights clinical efficacy data from a Phase 1b trial (PROC).show_traction
Open slide detail
18
The slide compares clinical outcomes (ORR, SD, CBR, PD) across four cohorts: two treatment groups and two historical control groups.compare_peers
Open slide detail
19
Includes trial design diagram with randomization and endpoint hierarchy.plan_implementation
Open slide detail
20
The slide uses qualitative feedback from healthcare providers and KOLs to validate market demand.show_traction
Open slide detail
21
front_matter
Open slide detail
22
The slide uses a process flow diagram to illustrate the trial structure.present_framework
Open slide detail
23
The slide includes detailed footnotes explaining specific adverse events and patient outcomes.analyze_data
Open slide detail
24
Includes footnotes comparing results to historical METEOR and CANTATA studies.show_traction
Open slide detail
25
Data compares low vs high biomarker groups across different dosage cohorts.analyze_data
Open slide detail
26
The slide outlines a clinical trial protocol including randomization, interim analysis for accelerated approval, and primary/secondary endpoints.plan_implementation
Open slide detail
27
The slide uses a table to summarize key value propositions and speech bubbles to provide direct KOL validation.illustrate_case
Open slide detail
28
The slide features a photo of a patient being comforted, emphasizing the human element of the medical treatment.front_matter
Open slide detail
29
The slide outlines a standard clinical trial schema with a dose-finding/safety phase followed by a randomized efficacy phase.plan_implementation
Open slide detail
30
Data cutoff date is August 18, 2022. N=21 patients.analyze_data
Open slide detail
31
Includes a footnote comparing results to a historical P3 study.show_traction
Open slide detail
32
Swimmer plot showing patient IDs on y-axis and weeks on study on x-axis, with various clinical status markers.analyze_data
Open slide detail
33
Data shows a clear correlation between achieving MEC and better clinical outcomes in PDAC patients.analyze_data
Open slide detail
34
PDAC stands for Pancreatic Ductal Adenocarcinoma. RP2D stands for Recommended Phase 2 Dose.plan_implementation
Open slide detail
35
Includes qualitative feedback from KOLs and healthcare providers regarding clinical utility and patient selection.argue_timing
Open slide detail
36
The slide uses a horizontal timeline with four distinct time periods, each containing multiple clinical trial or regulatory events.plan_implementation
Open slide detail
37
Data as of 6/30/2022.summarize
Open slide detail
38
summarize
Open slide detail
39
front_matter
Open slide detail